CN106883266B - Preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone and intermediate thereof - Google Patents
Preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone and intermediate thereof Download PDFInfo
- Publication number
- CN106883266B CN106883266B CN201710049273.9A CN201710049273A CN106883266B CN 106883266 B CN106883266 B CN 106883266B CN 201710049273 A CN201710049273 A CN 201710049273A CN 106883266 B CN106883266 B CN 106883266B
- Authority
- CN
- China
- Prior art keywords
- cyclopropyl
- formula
- compound shown
- chlorphenyl
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 4-chlorphenyl Chemical group 0.000 title claims abstract description 27
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 24
- 239000002904 solvent Substances 0.000 claims abstract description 20
- HVCFCNAITDHQFX-UHFFFAOYSA-N 1-cyclopropylethanone Chemical compound CC(=O)C1CC1 HVCFCNAITDHQFX-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000003054 catalyst Substances 0.000 claims abstract description 10
- 230000002378 acidificating effect Effects 0.000 claims abstract description 5
- 239000003513 alkali Substances 0.000 claims abstract description 5
- LRWCURGZPQWMRG-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-cyclopropylpropan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(=O)C(C)C1CC1 LRWCURGZPQWMRG-UHFFFAOYSA-N 0.000 claims description 19
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 238000006546 Horner-Wadsworth-Emmons reaction Methods 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 239000002585 base Substances 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 claims description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000005489 p-toluenesulfonic acid group Chemical group 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 6
- 238000009776 industrial production Methods 0.000 abstract description 5
- 239000002699 waste material Substances 0.000 abstract description 2
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 37
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 21
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 239000007818 Grignard reagent Substances 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 150000004795 grignard reagents Chemical class 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 4
- 239000005757 Cyproconazole Substances 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- ASFHBXWIBSPACX-UHFFFAOYSA-N 1-[1-(4-chlorophenyl)cyclopropyl]ethanone Chemical compound C=1C=C(Cl)C=CC=1C1(C(=O)C)CC1 ASFHBXWIBSPACX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- XWQYSORCBYSVKR-UHFFFAOYSA-N (4-chlorophenyl)-dimethoxyphosphorylmethanol Chemical compound COP(=O)(OC)C(O)C1=CC=C(Cl)C=C1 XWQYSORCBYSVKR-UHFFFAOYSA-N 0.000 description 1
- OWXJKYNZGFSVRC-NSCUHMNNSA-N (e)-1-chloroprop-1-ene Chemical compound C\C=C\Cl OWXJKYNZGFSVRC-NSCUHMNNSA-N 0.000 description 1
- JLALSRODUTZZPW-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-cyclopropylethanol Chemical compound C=1C=C(Cl)C=CC=1C(O)CC1CC1 JLALSRODUTZZPW-UHFFFAOYSA-N 0.000 description 1
- GJODRJDLQVBTMF-UHFFFAOYSA-N 1-(4-chlorophenyl)but-3-en-1-ol Chemical compound C=CCC(O)C1=CC=C(Cl)C=C1 GJODRJDLQVBTMF-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L Zinc chloride Inorganic materials [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
- QLKISOCKGGPANH-UHFFFAOYSA-N acetonitrile;chlorobenzene Chemical compound CC#N.ClC1=CC=CC=C1 QLKISOCKGGPANH-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- FJBFPHVGVWTDIP-UHFFFAOYSA-N dibromomethane Chemical compound BrCBr FJBFPHVGVWTDIP-UHFFFAOYSA-N 0.000 description 1
- LXCYSACZTOKNNS-UHFFFAOYSA-N diethoxy(oxo)phosphanium Chemical compound CCO[P+](=O)OCC LXCYSACZTOKNNS-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- CZHYKKAKFWLGJO-UHFFFAOYSA-N dimethyl phosphite Chemical compound COP([O-])OC CZHYKKAKFWLGJO-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- DHNUAKOQUGJUGA-UHFFFAOYSA-N silicon;sulfane Chemical compound [Si].S DHNUAKOQUGJUGA-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
- C07C45/60—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to a preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone, which is prepared from α -hydroxy p-chlorobenzyl phosphonate shown in formula I and 3,4-2HThe preparation method comprises the following steps of (1) -dihydropyran as a raw material, preparing a compound shown in a formula II in the presence of a catalyst, reacting the compound shown in the formula II with cyclopropyl methyl ketone in the presence of alkali and a solvent to obtain a compound shown in a formula III, and hydrolyzing the compound shown in the formula III in an acidic condition to obtain 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone, wherein α -hydroxy p-chlorobenzyl phosphonate and 3, 4-2-propyl phosphonate shown in the formula IHThe dihydropyran is used as a raw material, the raw material is cheap and easy to obtain, the steps are simple, the cost is low, the three-waste pollution is less, the environment is protected, the method is suitable for industrial production, and the finally prepared 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone has high purity, the content of more than 96 percent, high yield and the yield of more than 83 percent.
Description
Technical Field
The invention relates to a preparation method of a fungicide cyproconazole intermediate, in particular to a preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone and an intermediate thereof.
Background
Cyproconazole (cyproconazole) is a triazole bactericide developed by Sandoz AG, switzerland, is a systemic bactericide, has protective, therapeutic and virus-eradicating effects, and is widely used in western europe and north america. 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone is a key intermediate for the synthesis of cyproconazole. At present, various methods for preparing 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone have been reported, for example, chinese patent CN201110432969 discloses a method for preparing 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone, which has the following reaction formula:
US4973767 discloses a method for synthesizing 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone by a Grignard reagent method. Chloropropene and magnesium are adopted to generate a Grignard reagent, the Grignard reagent reacts with p-chlorobenzaldehyde to obtain 4- (4-chlorphenyl) -1-butene-4-ol, the Grignard reagent and dibromomethane are cyclized under the action of zinc and cuprous chloride to obtain 1- (4-chlorphenyl) -2-cyclopropyl ethanol, the cyclization is carried out under the action of oxalyl chloride, triethylamine and the like to obtain 4-chlorphenyl cyclopropyl methyl ketone, and the 4-chlorphenyl cyclopropyl methyl ketone reacts with sodium hydride and methyl iodide in a tetrahydrofuran solvent to obtain the target. The use of a Grignard reagent and sodium hydride is required, the requirement on the water content of a reaction system is high, and the method is not suitable for industrial production.
CN101786948 discloses a method for obtaining 1- (4-chlorophenyl) -2-cyclopropyl-1-acetone by condensation, hydrogenation and oxidation of raw materials comprising cyclopropyl methyl ketone, p-chlorobenzene acetonitrile and sodium hydride, wherein the method also needs to use sodium hydride, has strict requirements for the water content of a reaction system, has unsafe factors in magnesium powder reduction operation, is easy to self-polymerize, and is not suitable for industrial large-scale production.
The reported methods for the preparation of 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone also include: for example, CN102603508, CN101125807A, CN101857576A, CN102942465, etc. However, the method has the problems of high production cost, use of dangerous chemicals, difficult control of reaction conditions, potential safety hazards, non-conformity with green environmental protection requirements and the like, and is not beneficial to industrial production.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide an economical, green and environment-friendly preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone suitable for industrial production.
Another object of the present invention is to provide an intermediate of 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone and a preparation method thereof.
In order to solve the technical problems, the invention adopts the following technical scheme:
an intermediate of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone, which is a compound shown as II,
wherein R is an alkyl group having 1 to 5 carbon atoms,
or the intermediate is an alkoxy propylene derivative shown in a formula III,
the other technical scheme adopted by the invention is as follows: a method for preparing an intermediate of 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone, said method comprising the steps of:
(1) α -hydroxy p-chlorobenzyl phosphonate shown in the formula I and 3, 4-2H-dihydropyran react under the conditions of catalyst, solvent and 20-120 ℃ to obtain the compound shown in the formula II,
wherein R is alkyl with 1-5 carbon atoms, preferably, R is methyl or ethyl.
(2) Carrying out Horner-Wadsworth-Emmons reaction on the compound shown in the formula II prepared in the step (1) and cyclopropyl methyl ketone under the conditions of alkali, solvent and-78-120 ℃ to obtain a compound shown in a formula III, namely the intermediate,
further, in the step (1), the feeding molar ratio of the α -hydroxy-p-chlorobenzyl phosphonate, the 3, 4-2H-dihydropyran and the catalyst is 1: 1.0-3: 0.01-1.
Further preferably, the feeding molar ratio of the α -hydroxy-p-chlorobenzyl phosphonate, the 3, 4-2H-dihydropyran and the catalyst is 1: 1.0-2.5: 0.01-0.50.
Further, in the step (1), the catalyst is p-toluenesulfonic acid.
Further, in the step (1), the solvent is one or more of toluene, tetrahydrofuran, chloroform, 1, 2-dichloroethane and 1, 4-dioxane.
Further preferably, in the step (1), the solvent is one or a combination of several of toluene, tetrahydrofuran and 1, 2-dichloroethane.
Further, in the step (1), the reaction is carried out at 30 to 110 ℃.
Further preferably, the reaction is carried out at 30 ℃ to 60 ℃.
Further, the specific implementation mode of the step (1) is that α -hydroxy-p-chlorobenzyl phosphonate is dissolved in a solvent, then the 3, 4-2H-dihydropyran and a catalyst are sequentially added, and the reaction is carried out for 1-12 hours at the temperature of 30-60 ℃.
Further, the preparation method also comprises a step of carrying out post-treatment after the reaction in the step (1) is finished, and the preparation method is implemented specifically as follows: and washing and layering the reaction solution after the reaction by using a sodium hydroxide solution, drying and concentrating the organic phase to obtain the compound shown in the formula II, and further purifying the compound shown in the formula II or directly using the compound shown in the next step.
Further, in the step (2), the compound shown in the formula II, the cyclopropyl methyl ketone and the base are fed in a molar ratio of 1: 1.0-2: 1.0 to 2.
Further preferably, the compound shown in the formula II, the cyclopropyl methyl ketone and the base are fed in a molar ratio of 1: 1.1-1.8: 1.1 to 1.8.
Further, in the step (2), the base is one or more of n-butyl lithium, lithium diisopropylamide, sodium hydride, sodium amide, sodium tert-butoxide and potassium tert-butoxide.
Further, in the step (2), the Horner-Wadsworth-Emmons reaction is carried out at-78 ℃ to 100 ℃.
Further preferably, in the step (2), the Horner-Wadsworth-Emmons reaction is carried out at-78 ℃ to 50 ℃.
Further, in the step (2), the solvent is one or a combination of several of toluene, tetrahydrofuran, dimethyl sulfoxide, N-dimethylformamide, N-methylpyrrolidone, N-butanol, isobutanol and tert-butanol.
Further preferably, in the step (2), the solvent is one or a combination of several of toluene, tetrahydrofuran, dimethyl sulfoxide, N-dimethylformamide and tert-butanol.
Further, the specific implementation manner of step (2) is as follows: dissolving the compound shown in the formula II prepared in the step (1) and cyclopropyl methyl ketone in a solvent, adding the alkali at the temperature of-78-15 ℃, and reacting for 2-16 hours at the temperature of 15-120 ℃ after the addition is finished.
Further, the preparation method further comprises a step of carrying out post-treatment after the reaction in the step (2) is finished, and the preparation method is implemented specifically as follows: after the Horner-Wadsworth-Emmons reaction is finished, adding water to extract and kill the reaction product, and concentrating the reaction product to obtain a crude compound shown in a formula III.
Further preferably, the crude compound shown in the formula III can be directly used for preparing 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone.
The invention adopts another technical scheme that: a process for the preparation of 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone comprising the steps of:
(a) preparing a compound represented by formula III according to the method;
(b) carrying out hydrolysis reaction on the compound shown in the formula III prepared in the step (a) under an acidic condition to obtain a compound shown in a formula IV, namely the 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone,
further, in the step (b), the acid selected for the acidic condition is one or a combination of acetic acid, hydrochloric acid, p-toluenesulfonic acid and sulfuric acid.
Further, in the step (b), the hydrolysis reaction is carried out at 0-80 ℃.
Further preferably, the hydrolysis reaction is carried out at 10 ℃ to 60 ℃.
Further, in the step (b), the solvent is one or a combination of several of water, methanol, ethanol, isopropanol, tert-butanol, 1, 4-dioxane, tetrahydrofuran, toluene, dichloromethane, 1, 2-dichloroethane, N-dimethylformamide and dimethylsulfoxide.
Further preferably, in the step (b), the solvent is one or a combination of several of water, methanol, ethanol, tetrahydrofuran and toluene.
Further, the specific implementation manner of the step (b) is as follows: dissolving the compound shown in the formula III prepared in the step (a) in a solvent, dropwise adding acid, and reacting for 0.5-3 hours at 0-80 ℃ after dropwise adding.
Further, the preparation method of the 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone further comprises the step of carrying out post-treatment after the reaction in the step (b), and the preparation method is implemented specifically as follows: after the reaction is finished, concentrating the reaction solution, separating and purifying to obtain the 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone.
Due to the implementation of the technical scheme, compared with the prior art, the invention has the following advantages:
the 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone is prepared by using α -hydroxy p-chlorobenzyl phosphonate shown in formula I and 3, 4-2H-dihydropyran as raw materials, the raw materials are cheap and easy to obtain, the steps are simple, the cost is low, the three-waste pollution is less, the method is green and environment-friendly and suitable for industrial production, and the finally prepared 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone has high purity, the content is more than 96%, the yield is high, and the yield is more than 83%.
Detailed Description
The present invention will be described in further detail with reference to specific examples. It is to be understood that these embodiments are provided to illustrate the basic principles, essential features and advantages of the present invention, and the present invention is not limited by the following embodiments. The implementation conditions used in the examples can be further adjusted according to specific requirements, and the implementation conditions not indicated are generally the conditions in routine experiments.
Example one
This example provides a method for preparing 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone, which comprises the following steps:
(1) α -hydroxy-p-chlorobenzylphosphonic acid dimethyl ester (prepared from p-chlorobenzaldehyde and dimethyl phosphite by the method described in J.Organomet.Chem.2016,804, 59-65; Phosphorus, Sulfur Silicon Relat.Elem.2014,189,812-818 or J.Org.Chem.2014,79, 6172-6178) (2.51g,10.0mmol) was dissolved in toluene (50mL), followed by addition of 3, 4-2H-dihydropyran (841mg,10.0mmol) and p-toluenesulfonic acid (190mg,1.0 mmol). after the reaction was stirred at 50 ℃ for 5 hours, the reaction solution was washed with sodium hydroxide solution (20mL) and the organic layer was concentrated under reduced pressure to remove toluene.the crude product was purified by column chromatography (petroleum ether: ethyl acetate 3:1) to give the compound of formula II (R is methyl) (3.05% yield 95%).
1H NMR(400MHz,CDCl3)δ(ppm)7.43(1H,dd,J1＝1.6Hz,J2＝8.4Hz),7.38(1H,dd,J1＝1.6Hz,J2＝8.4Hz),7.32(2H,d,J＝8.4Hz),5.11(0.46H,s),5.06(0.65H,d,J＝17.2Hz),4.97 (0.47H,d,J＝12.0Hz),4.49(0.65H,s),3.96-4.17(6H,m),3.13-3.55(1H,m),3.33-3.38(1H,m), 1.40-1.85(6H,m).
(2) The compound represented by the formula II (1.67g,5.0mmol) obtained in step (1) was dissolved in N, N-dimethylformamide (5.0mL), followed by the addition of cyclopropylmethyl ketone (505mg,6.0mmol) and sodium amide (234mg,6.0mmol) in that order. The reaction solution was stirred at 40 ℃ for 3 hours. After completion of the reaction, water (10mL) was added to the reaction, and the resulting mixture was extracted with ethyl acetate (three times 10mL each). The resulting organic phases were combined, dried over sodium sulfate and concentrated to give a crude compound represented by formula III (1.51g), content 80.1%, yield 83%.
1H NMR(400MHz,CDCl3)δ(ppm)7.44(2H,d,J＝6.0Hz),7.20(2H,d,J＝6.0Hz),4.88(1H, t,J＝4.8Hz),3.72-3.76(1H,m),3.63-3.66(1H,m),1.96-2.01(1H,m),1.71-1.77(2H,m),1.66 (3H,s),1.55-1.65(3H,m),1.19-1.27(1H,m),0.47-0.56(2H,m),0.25-0.31(2H,m).
(3) The compound represented by the formula III (1.51g) obtained in step (2) was dissolved in tetrahydrofuran (5.0mL), and a hydrochloric acid solution (6N, 1.5mL) was added to the solution. The reaction solution was stirred at 25 ℃ for 30 minutes. After the reaction was completed, the solvent was distilled off under reduced pressure. The crude product was purified by column chromatography (petroleum ether: ethyl acetate ═ 20:1) to give 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone (0.86g) as a colorless oily compound with a content of 98% and a yield of 83%.
Example two
This example provides a method for preparing 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone, which comprises the following steps:
(1) α -diethyl p-chlorobenzylphosphonate (prepared from p-chlorobenzaldehyde and diethyl phosphite as described in Tetrahedron Lett.2004,45, 9233-.
1H NMR(400MHz,CDCl3)δ(ppm)7.43(1H,dd,J1＝1.6Hz,J2＝8.4Hz),7.38(1H,dd,J1＝1.6Hz,J2＝8.4Hz),7.32(2H,d,J＝8.4Hz),5.10(0.46H,s),5.05(0.65H,d,J＝17.2Hz),4.96 (0.47H,d,J＝12.0Hz),4.48(0.66H,s),3.96-4.17(4.3H,m),3.53-3.55(0.69H,m),3.33-3.38 (1H,m),1.40-1.85(6H,m),1.22-1.30(6H,m).
(2) The compound represented by the formula II (1.81g,5.0mmol) obtained in step (1) was dissolved in N, N-dimethylformamide (5.0mL), followed by the addition of cyclopropylmethyl ketone (505mg,6.0mmol) and sodium amide (234mg,6.0mmol) in that order. The reaction solution was stirred at 40 ℃ for 3 hours. After completion of the reaction, water (10mL) was added to the reaction, and the resulting mixture was extracted with ethyl acetate (three times 10mL each). The resulting organic phases were combined, dried over sodium sulfate and concentrated to give a crude compound of formula III (1.55g), 82% in content and 87% in yield.
(3) The compound represented by the formula III (1.55g) obtained in step (2) was dissolved in tetrahydrofuran (5.0mL), and a hydrochloric acid solution (6N, 1.5mL) was added to the solution. The reaction solution was stirred at 25 ℃ for 30 minutes. After the reaction was completed, the solvent was distilled off under reduced pressure. The crude product was purified by column chromatography (petroleum ether: ethyl acetate ═ 20:1) to give 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone (0.90g) as a colorless oily compound with a content of 97% and a yield of 87%.
EXAMPLE III
This example provides a method for preparing 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone, which comprises the following steps:
(1) a tetrahydrofuran (10.0mL) solution containing diisopropylamine (0.51g, 5.0mmol) was cooled to-78 deg.C, and n-butyllithium (3.1mL,1.6M) was added dropwise to the solution, and the resulting solution was stirred at 0 deg.C for 30 minutes and then cooled to-40 deg.C. Subsequently, the compound represented by the formula II (1.81g,5.0mmol) obtained in the second step (1) of example and cyclopropylmethyl ketone (505mg,6.0mmol) were added dropwise to the reaction system in this order, and the reaction mixture was allowed to spontaneously rise to 0 ℃ and stirred at that temperature for 3 hours. After the reaction, the reaction solution was cooled to 0 ℃ and saturated ammonium chloride solution (10mL) was added dropwise to quench the reaction. Extract with ethyl acetate (three times 15mL each). The resulting organic phases were combined, dried over sodium sulfate and concentrated to give a crude compound of formula III (1.50g), 86% in content and 88% in yield.
(2) The compound represented by the formula III (1.50g) obtained in step (1) was dissolved in tetrahydrofuran (5.0mL), and a 30% dilute sulfuric acid solution (1.0mL) was added to the solution. The reaction solution was stirred at 25 ℃ for 30 minutes. After the reaction was completed, the solvent was distilled off under reduced pressure. The crude product was purified by column chromatography (petroleum ether: ethyl acetate ═ 20:1) to give 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone (0.93g) as a colorless oily compound with a content of 96% and a yield of 89%.
Example four
This example provides a method for preparing 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone, which comprises the following steps:
(1) the compound represented by the formula II (1.81g,5.0mmol) obtained in example two step (1) was dissolved in N, N-dimethylformamide (5.0mL), followed by the addition of cyclopropylmethyl ketone (505mg,6.0mmol) and potassium tert-butoxide (673mg,6.0mmol) in that order. The reaction solution was stirred at 40 ℃ for 3 hours. After completion of the reaction, water (10mL) was added to the reaction, and the resulting mixture was extracted with ethyl acetate (three times 10mL each). The resulting organic phases were combined, dried over sodium sulfate and concentrated to give a crude compound of formula III (1.60g), 80% in content and 88% in yield.
(2) The compound represented by the formula III (1.60g) obtained in step (1) was dissolved in ethanol (5.0mL), and p-toluenesulfonic acid (95.1mg,0.5mmol) was added to the solution. The reaction solution was stirred at 40 ℃ for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure. The crude product was purified by column chromatography (petroleum ether: ethyl acetate ═ 20:1) to give 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone (0.96g) as a colorless oily compound, content 96%, yield 92%.
The present invention is described in detail in order to make those skilled in the art understand the content and practice the invention, and the invention is not limited to the above embodiments, and all equivalent changes or modifications made according to the spirit of the invention should be covered by the scope of the invention.
Claims (5)
1. A preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone is characterized by comprising the following steps:
(1) α -hydroxy-p-chlorobenzyl phosphonate shown in the formula I and 3, 4-2H-dihydropyran react under the conditions of catalyst, solvent and 20-50 ℃ to obtain a compound shown in the formula II, the feeding molar ratio of α -hydroxy-p-chlorobenzyl phosphonate, 3, 4-2H-dihydropyran and catalyst is 1: 1.0-3: 0.01-1, the catalyst is p-toluenesulfonic acid,
wherein R is an alkyl group having 1-5 carbon atoms;
(2) carrying out Horner-Wadsworth-Emmons reaction on the compound shown in the formula II prepared in the step (1) and cyclopropyl methyl ketone under the conditions of alkali, solvent and-78-120 ℃ to obtain a compound shown in a formula III, namely the intermediate, wherein the alkali is one or a combination of more of n-butyl lithium, lithium diisopropylamide, sodium tert-butoxide and potassium tert-butoxide;
(3) carrying out hydrolysis reaction on the compound shown in the formula III prepared in the step (2) under an acidic condition to obtain a compound shown in a formula IV, namely the 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone,
2. the method for preparing an intermediate of 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone according to claim 1, wherein the specific embodiment of step (1) is that α -hydroxy-p-chlorobenzyl phosphonate is dissolved in a solvent, and then the 3, 4-2H-dihydropyran and the catalyst are sequentially added to react for 1-12 hours at 30-50 ℃.
3. The process for producing an intermediate of 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone according to claim 1, wherein in step (2), the compound represented by the formula II, cyclopropyl methyl ketone and base are fed in a molar ratio of 1: 1.0-2: 1.0 to 2.
4. The method for preparing 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone according to claim 1, wherein in step (3), the acid selected for use in said acidic conditions is one or a combination of acetic acid, hydrochloric acid, p-toluenesulfonic acid and sulfuric acid.
5. The process for preparing 1- (4-chlorophenyl) -2-cyclopropyl-1-propanone according to claim 1, wherein the embodiment of step (b) is: dissolving the compound shown in the formula III prepared in the step (a) in a solvent, dropwise adding acid, and reacting for 0.5-3 hours at 0-80 ℃ after dropwise adding.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710049273.9A CN106883266B (en) | 2017-01-23 | 2017-01-23 | Preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone and intermediate thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710049273.9A CN106883266B (en) | 2017-01-23 | 2017-01-23 | Preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone and intermediate thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106883266A CN106883266A (en) | 2017-06-23 |
| CN106883266B true CN106883266B (en) | 2020-03-17 |
Family
ID=59175826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710049273.9A Active CN106883266B (en) | 2017-01-23 | 2017-01-23 | Preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone and intermediate thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106883266B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110734364B (en) * | 2019-12-04 | 2022-09-23 | 上海生农生化制品股份有限公司 | A kind of synthetic method of 1-(4-chlorophenyl)-2-cyclopropyl-1-acetone |
| CN113121322B (en) * | 2019-12-30 | 2024-10-29 | 辽宁众辉生物科技有限公司 | Synthesis method of 1- (4-chlorophenyl) -2-cyclopropyl-1-acetone |
| CN115385784B (en) * | 2021-05-19 | 2024-02-13 | 顺毅股份有限公司 | Preparation method of 1- (4-chlorophenyl) -2-cyclopropyl-1-acetone |
| CN114195625B (en) * | 2021-11-30 | 2023-12-01 | 江苏剑牌农化股份有限公司 | Preparation method of 1- (4-chlorophenyl) -2-cyclopropyl-1-acetone |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010070060A1 (en) * | 2008-12-19 | 2010-06-24 | Nerviano Medical Sciences S.R.L. | Bicyclic pyrazoles as protein kinase inhibitors |
| CN102105459A (en) * | 2008-07-24 | 2011-06-22 | 内尔维阿诺医学科学有限公司 | 3,4-diarylpyrazoles as protein kinase inhibitors |
| CN106279058A (en) * | 2015-06-08 | 2017-01-04 | 沈阳药科大学 | The preparation of 3,4-diaryl-1,2,5-diazole oxide and purposes |
| CN106316808A (en) * | 2016-08-16 | 2017-01-11 | 江苏七洲绿色化工股份有限公司 | Preparation method of 1-(4-chlorphenyl)-2-cyclopropyl-1-acetone |
-
2017
- 2017-01-23 CN CN201710049273.9A patent/CN106883266B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102105459A (en) * | 2008-07-24 | 2011-06-22 | 内尔维阿诺医学科学有限公司 | 3,4-diarylpyrazoles as protein kinase inhibitors |
| WO2010070060A1 (en) * | 2008-12-19 | 2010-06-24 | Nerviano Medical Sciences S.R.L. | Bicyclic pyrazoles as protein kinase inhibitors |
| CN106279058A (en) * | 2015-06-08 | 2017-01-04 | 沈阳药科大学 | The preparation of 3,4-diaryl-1,2,5-diazole oxide and purposes |
| CN106316808A (en) * | 2016-08-16 | 2017-01-11 | 江苏七洲绿色化工股份有限公司 | Preparation method of 1-(4-chlorphenyl)-2-cyclopropyl-1-acetone |
Non-Patent Citations (2)
| Title |
|---|
| Phosphonate Reagents for the Synthesis of Enol Ethers and One-Carbon Homologation to Aldehydes;Arthur F. Kluge et al;《J. Org. Chem》;19781231;第44卷;第4847-4852页 * |
| 杀菌剂环唑醇的合成研究;游华南等;《现代农药》;20041231;第3卷;第10-12页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106883266A (en) | 2017-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106883266B (en) | Preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone and intermediate thereof | |
| JP6137492B2 (en) | ω-halo-2-alkynal and process for producing conjugated Z-alkeneinyl acetate using the same | |
| ITMI991486A1 (en) | PROCESS FOR THE SYNTHESIS OF CITALOPRAM | |
| WO2008015977A1 (en) | PROCESS FOR PRODUCTION OF (±)-3a,6,6,9a– TETRAMETHYLDECAHYDRONAPHTHO[2,1-b]FURAN-2(1H)-ONE | |
| CN105646311B (en) | The method that one kind prepares the carrot aldehyde of β Apos 8 ' | |
| CN107954962A (en) | A kind of 4,4- dihalos oxinane preparation method | |
| CN114605262A (en) | A kind of efficient and selective synthesis method of phenylallyl ether compounds | |
| US10562834B2 (en) | Process for preparing substituted crotonic acids | |
| EP3066087B1 (en) | A process for the preparation of olopatadine and sylil intermediates thereof | |
| KR101821685B1 (en) | Process for Preparing Beraprost Intermediate | |
| CN107602337B (en) | Preparation method of 1,4-dicyano-2-butene | |
| CN114539125B (en) | Synthesis method of paciclovir intermediate | |
| CN114105745B (en) | Octabolmod intermediate and preparation method thereof | |
| JP2010235589A (en) | 4-Polyfluoroacylphenyl alkyl ketone and method for producing the same | |
| JP5476549B2 (en) | Process for producing 2,3-dihydro-thieno [3,4-b] furan derivative and novel compound used therefor | |
| WO2005014519A1 (en) | Process for the preparation of geminal difluoroalkanes | |
| JP3254745B2 (en) | Diol compound and method for producing the same | |
| JP2007254293A (en) | Process for producing α-methylene-β-alkyl-γ-butyrolactone | |
| CN111039739A (en) | Preparation method of 1, 4-bis (2-methyl styryl) benzene | |
| Ishmuratov et al. | Transformation of peroxide products of (S)-(-)-limonene ozonolysis in the system HCl-methanol | |
| JP5573079B2 (en) | Method for producing 3-mercapto-1-propanol | |
| KR100570279B1 (en) | Intermediates of coenzyme Ｑｎ and methods for preparing the intermediate | |
| CN102976993A (en) | Synthetic method of 3-hydroxyazetidine hydrochloride | |
| CN111848521A (en) | Preparation method of 2-substituted-4-alkoxy imidazole compound | |
| Gong | Total Synthesis of Maoecrystal V |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |